Abstract:ABSTRACT Tuberculous meningitis (TBM) is a severe infectious disease affecting the central nervous system, causing high mortality and disability. However, current diagnostic methods for TBM using cerebrospinal fluid (CSF) lack sensitivity and predictive biomarkers for prognosis. We conducted a study on cytokine profiles in CSF and serum samples from TBM patients to identify disease-specific biomarkers. Patients were categorized into three groups: TBM ( n = 17), cryptococcal meningitis ( n = 10), and non-infection ( n = 6), and cytokine levels were quantified using a 48-plex panel. After treatment, we observed a significant reduction in the levels of 12 cytokines, indicating their potential use as biomarkers for treatment monitoring. Among them, monokine induced by interferon-γ (MIG) and interleukin-18 showed significant differences in serum or CSF cytokine levels compared to the control groups. CSF levels of MIG in TBM patients were negatively correlated with the CSF/blood glucose ratio ( r = −0.4728, P = 0.0475). Positive correlations were found between CSF leukocyte counts and several cytokines, including fibroblast growth factor-basic, granulocyte colony-stimulating factor (G-CSF), monocyte chemotactic protein-3, macrophage inflammatory protein 1 alpha (MIP-1α), and tumor necrosis factor alpha. G-CSF and MIP-1α were also positively correlated with CSF protein levels. Receiver operating characteristic curve analysis revealed that MIG exhibited the highest area under the curve of 0.92 [95% confidence interval (CI) 0.82–1.00] with a sensitivity of 0.85 (95% CI 0.58–0.97) and a specificity of 0.87 (95% CI 0.62–0.98), making it a promising diagnostic biomarker for TBM. Our study provides valuable insights into TBM’s pathogenesis and identifies potential biomarkers for diagnosis and evaluating treatment monitoring. IMPORTANCE Tuberculous meningitis is a life-threatening infection with high mortality and disability rates. Current diagnostic methods using cerebrospinal fluid (CSF) samples have limited sensitivity and lack predictive biomarkers for evaluating prognosis. This study’s findings reveal excessive activation of the immune response during tuberculous meningitis (TBM) infection. Notably, a strong negative correlation was observed between CSF levels of monokine induced by interferon-γ (MIG) and the CSF/blood glucose ratio in TBM patients. MIG also exhibited the highest area under the curve with high sensitivity and specificity. This study suggests that MIG may serve as a novel biomarker for differentiating TBM infection in CSF or serum, potentially leading to improved diagnostic accuracy and better patient outcomes.

Cerebrospinal Fluid Metabolomic Profiling in Tuberculous and Viral Meningitis: Screening Potential Markers for Differential Diagnosis

Elevated Host Lipid Metabolism Revealed by Itraq-Based Quantitative Proteomic Analysis of Cerebrospinal Fluid of Tuberculous Meningitis Patients.

Identification of protein biomarkers in host cerebrospinal fluid for differential diagnosis of tuberculous meningitis and other meningitis

Systemic and cerebrospinal fluid biomarkers for tuberculous meningitis identification and treatment monitoring

Metabolomic analysis of human cerebrospinal fluid in patients with tuberculous meningitis using ultra high performance liquid chromatography tandem mass spectrometry

The Feasibility of Metagenomic Next-Generation Sequencing to Identify Pathogens Causing Tuberculous Meningitis in Cerebrospinal Fluid

Genome-Wide Mirna Analysis Identifies Potential Biomarkers in Distinguishing Tuberculous and Viral Meningitis

CSF Metabolomics of Tuberculous Meningitis: A Review

An Itraq Approach to Quantitative Proteome Analysis of Cerebrospinal Fluid from Patients with Tuberculous Meningitis.

Performance of metagenomic next-generation sequencing in cerebrospinal fluid for diagnosis of tuberculous meningitis

Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis.

Application of 1H NMR spectroscopy-based metabolomics to sera of tuberculosis patients

Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid

Recent advances in microbiological and molecular biological detection techniques of tuberculous meningitis

Metagenomic next generation sequencing for the diagnosis of tuberculosis meningitis: A systematic review and meta-analysis

Development and Validation of a New Scoring System for the Early Diagnosis of Tuberculous Meningitis in Adults

Metabolomics Specificity of Tuberculosis Plasma Revealed by (1)H NMR Spectroscopy.

Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis

Tuberculostearic acid incorporated predictive model contributes to the clinical diagnosis of tuberculous meningitis

Serum Metabolomic Study For The Detection Of Candidate Biomarkers Of Tuberculosis

The diagnostic potential of urine in paediatric patients undergoing initial treatment for tuberculous meningitis